Release Date: December 2002
Summary of Recommendations / Supporting Documents
Rating: I recommendation.
Rationale: The USPSTF found good evidence that PSA screening can detect early-stage prostate cancer but mixed and inconclusive evidence that early detection improves health outcomes. Screening is associated with important harms, including frequent false-positive results and unnecessary anxiety, biopsies, and potential complications of treatment of some cancers that may never have affected a patient's health. The USPSTF concludes that evidence is insufficient to determine whether the benefits outweigh the harms for a screened population.Screening for Prostate Cancer, 2002
Recommendations and Rationale (PDF File, 65 KB)
Summary of the Evidence (PDF File, 141 KB)
Systematic Evidence Review (File Download, 219 KB)
What's New (PDF File, 79 KB)
USPSTF Topic Index
USPSTF Clinical Categories
U.S. Preventive Services Task Force